Thomas J Ow

Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites

Mei Zhao, David Sidransky, Gary L Clayman, 2011, Clinical Cancer Research.

Disruptive TP53 Mutation Is Associated with Aggressive Disease Characteristics in an Orthotopic Murine Model of Oral Tongue Cancer

Mei Zhao, Richard A Gibbs, Jeffrey N Myers, 2011, Clinical Cancer Research.

Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.

Olivier Lichtarge, Marek Kimmel, Thomas O McDonald, 2015, Cancer research.

Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer.

Olivier Lichtarge, Marek Kimmel, Beth M Beadle, 2015, Cancer research.